MedPath

The Influence of Infant Feeding Type on Preterm Infant's Intestinal Microbiome

Conditions
Microbial Colonization
Registration Number
NCT04972214
Lead Sponsor
CHA University
Brief Summary

This study aims to examine the factors associated with preterm infant's intestinal microbiota depending on feeding type (breast milk or preterm formula)

Detailed Description

The gut microbiome has been increasingly found to affect human health. Feeding plays an important role in determining the composition and diversity of the neonatal gut microbiome. Preterm infants are at a high risk of gut microbiota disruption and dysbiosis because of physiological immaturity and environmental factors. In preterm infants, breast milk has been associated with improved growth and cognitive development and a reduced risk of necrotizing enterocolitis and late onset sepsis.

The objective of study is to determine the impact of feeding type on gut microbiome of very preterm infants admitted in a neonatal intensive care unit (NICU). Meconium and the additional 2 fecal samples will be collected from preterm infants. Fecal samples will be collected every 14 days, during 28 days, from diapers into sterile tubes. DNA will be extracted from fecal samples and different bacterial genus and species will be analyzed.

The type of infant feeding (breast milk or preterm formula) is recorded daily to classify the type of infant feeding received during the 14 days prior to each fecal sample collection.

Recruitment & Eligibility

Status
UNKNOWN
Sex
All
Target Recruitment
50
Inclusion Criteria
  • Very preterm infants (< 32 weeks gestational age) admitted in the NICU of CHA Bundang Medical Center within the first 24 hours after birth
Exclusion Criteria
  • Parents refuse to participate/sign informed consent
  • Major congenital anomalies

Study & Design

Study Type
OBSERVATIONAL
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
intestinal microbiome composition according to the type of feeding4 weeks after birth

comparison of intestinal microbiome with 16s RNA gene specific sequencing

Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (1)

CHA Bundang Medical center

🇰🇷

Seongnam, Gyeonggi-do, Korea, Republic of

© Copyright 2025. All Rights Reserved by MedPath